Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome

NCT01485978 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Renal Insufficiency, Chronic

Interventions

DRUG: Ramipril
DRUG: placebo to ramipril
DRUG: Ramipril

Sponsor

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

Collaborators

[object Object]
[object Object]